PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Lobbying for PHARMA & BIOPHARMA OUTSOURCING ASSOCIATION

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New Jersey · $50,000.00 expenses · posted Jul 14, 2026

Lobbying activity 4

Manufacturing

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Pharmacy

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Tariff (miscellaneous tariff bills)

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Health Issues

Discussed issues related to biopharma supply chain tariff implementation, onshoring/friendshoring initiatives, robustness of biopharmaceutical supply chains, drug shortages, and workforce development

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.